[Ritonavir-boosted lopinavir monotherapy due to intolerance to nucleoside reverse transcriptase inhibitors in an HIV-infected paediatric patient]

Enferm Infecc Microbiol Clin. 2011 Apr;29(4):319. doi: 10.1016/j.eimc.2010.11.009. Epub 2011 Feb 18.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / adverse effects
  • Anti-HIV Agents / therapeutic use*
  • Child Behavior Disorders / chemically induced
  • Drug Resistance, Multiple, Viral / genetics
  • Drug Therapy, Combination
  • Gastrointestinal Diseases / chemically induced
  • HIV Infections / congenital
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors / administration & dosage
  • HIV Protease Inhibitors / adverse effects
  • HIV Protease Inhibitors / therapeutic use*
  • HIV Reverse Transcriptase / genetics
  • Humans
  • Kidney Calculi / chemically induced
  • Lopinavir
  • Male
  • Mutation, Missense
  • Pyrimidinones / administration & dosage
  • Pyrimidinones / therapeutic use*
  • Reverse Transcriptase Inhibitors / adverse effects*
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Ritonavir / administration & dosage
  • Ritonavir / adverse effects
  • Ritonavir / therapeutic use*

Substances

  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Pyrimidinones
  • Reverse Transcriptase Inhibitors
  • Lopinavir
  • reverse transcriptase, Human immunodeficiency virus 1
  • HIV Reverse Transcriptase
  • Ritonavir